AIP
INBX icon

Ameritas Investment Partners’s Inhibrx INBX Stock Holding History

Ameritas Investment Partners’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.5K Hold
736
– – ﹤0.01% 2096
2025
Q4 		$58.1K Sell
736
-117
-14% -$7.97K ﹤0.01% 2021
2025
Q3 		$28.7K Hold
853
– – ﹤0.01% 2501
2025
Q2 		$12.2K Hold
853
– – ﹤0.01% 2906
2025
Q1 		$11.9K Hold
853
– – ﹤0.01% 2762
2024
Q4 		$13.1K Hold
853
– – ﹤0.01% 2823
2024
Q3 		$13.4K Hold
853
– – ﹤0.01% 2827
2024
Q2 		$12.1K Buy
+853
New +$13.3K ﹤0.01% 2855

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameritas Investment Partners's INBX Position: Q1 2026 in Review

Ameritas Investment Partners held its Inhibrx (INBX) position steady in Q1 2026 at 736 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Ameritas Investment Partners first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $58.1K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Ameritas Investment Partners held 736 shares of Inhibrx worth $49.5K as of Q1 2026.
  • Ameritas Investment Partners left its Inhibrx share count unchanged in Q1 2026.
  • Inhibrx made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2096 holding.
  • Ameritas Investment Partners first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Ameritas Investment Partners's Inhibrx position peaked at $58.1K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.